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Abstract We here report the identification of the previously
uncharacterized SGD1 gene, encoding a 102.8-kDa protein
containing a leucine zipper region and a bipartite nuclear
localization signal. Deletion of SGD1 results in loss of cell
viability, while an increased dosage of SGD1 partially suppresses
the osmosensitivity of pbs2v and hog1v mutants that are
defective in the osmosignaling high osmolarity glycerol (HOG)
mitogen-activated protein kinase pathway. The rescued mutants
display a partially re-established transcriptional control of the
osmostress-induced expression of GPD1, a target gene of the
HOG pathway encoding NAD+-dependent glycerol 3-phosphate
dehydrogenase, and a partially recovered hyperosmolarity-
induced production of glycerol. Consistent with Sgd1p affecting
the transcriptional control of GPD1, a functional green
fluorescent protein tagged Sgd1p is localized to the cell
nucleus. ß 2000 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
In eukaryotic cells a variety of extracellular stimuli generate
signals that are transmitted from cell surface receptors
through multi-component signaling pathways to modify vari-
ous intracellular target molecules. In many instances, evolu-
tionarily well conserved mitogen-activated protein kinase
(MAPK) modules are key elements in transmitting the signals
to the downstream targets [1]. In the yeast Saccharomyces
cerevisiae several di¡erent MAPK cascades operate, each of
which is responding to di¡erent upstream signals and activat-
ing speci¢c downstream events [2,3]. Exposed to increased
osmolarity of the surrounding medium, S. cerevisiae activates
a MAPK cascade referred to as the HOG (high osmolarity
glycerol) MAPK pathway [4^6]. Activation of the HOG path-
way leads to a transient phosphorylation [4,7] and transport
of Hog1p into the nucleus [8,9] giving rise to transcriptional
activation of several genes, including GPD1 [10,11], encoding
cytosolic glycerol 3-phosphate dehydrogenase (GPD). In-
creased glycerol production and intracellular accumulation is
a key event in the adaptation of S. cerevisiae to hyperosmotic
stress [12,13], and this response is dependent on a functional
HOG pathway [4]. Deletion of the HOG1 or the PBS2 gene
causes decreased glycerol production following transfer to hy-
perosmolarity [4], with a marked decrease of the transcrip-
tional activation of the GPD1 gene [10,11]. It was recently
demonstrated that the short term transcriptional response to
hyperosmotic stress by GPD1 and other HOG pathway target
genes is dependent on the transcriptional factors Msn1p,
Msn2p, Msn4p, and the novel nuclear factor Hot1p [14].
Moreover, the osmotic induction of GPD1 was also found
to be dependent on the repressor/activator protein Rap1p
[15], suggesting that the full transcriptional activation requires
the cooperative interaction of a distinct set of factors.
Here we report the characterization of a novel gene, SGD1,
which was cloned by complementation of an osmostress-sen-
sitive, glycerol-defective mutant. The SGD1 gene encodes an
essential protein, which is localized to the nucleus and exhibits
a dosage-dependent suppression of the osmosensitive pheno-
type of pbs2v and hog1v mutants.
2. Materials and methods
2.1. Strains, media and growth conditions
S. cerevisiae strains used in this study were W303-1B MATK ade2-
1 can1-100 leu2-3/112 trp1-1 ura3-1 his3-11/15 [16] and the W303
derivatives U451 MATa ade2-1 can1-100‡ leu2-3/112 trp1-1 ura3-1
and H19 MATK ade2-1‡ can1-100‡ leu2-3/112 trp1-1 ura3-1
sup4 :pBR322:URA3:SUP4 his3-11/15 [17]. For suppression studies
isogenic hog1 : :LEU2 [10] or pbs2: :LEU2 [18] or hog1 : :TRP1
pbs2 : :LEU2 (this study) strains were used. The genotype of the dip-
loid strain having one SGD1 gene deleted was ade2-1/ade2-1 can1-100/
can1-100 leu2-3,112/leu2-3, 112 trp1-1/trp1-1 ura3-1/ura3-1 his3-11,15/
1 his3-11,15 SGD1/sgd1v : :LEU2. For linkage studies strain M2452K
MATK ura3ade6 (kindly supplied by M. Kielland-Brandt) was used.
Subcellular localization was conducted using strain ACY192 MATa
ura3-52 trp1v63 leu2vGAL (A.H. Corbett). The growth and main-
tenance of yeast strains were as previously described [18]. High osmo-
larity media were prepared by adding the appropriate amount of
NaCl, KCl or sorbitol.
Escherichia coli strains DH5K [19] and TG1 [20] were grown at
37‡C, in LB (Luria broth) supplemented with ampicillin (100 Wg/ml)
when required.
2.2. DNA techniques
All recombinant DNA techniques were carried out according to
standard protocols [20,21]. DNA fragments complementing an os-
motically sensitive mutant (osg3 mutant) were cloned using a
YCp50 DNA library [22] that was transformed into the osg3 mutant
and colonies restoring growth on YNB plates with 1.4 M NaCl were
picked for further analysis. Plasmid DNA was isolated and ampli¢ed
in E. coli. Restriction maps of the complementing fragments were
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constructed and subcloning was performed by cloning into the cen-
tromeric vector pRS316 [23] containing URA3 as the marker gene. A
4.8-kb SalI^SalI subclone, containing the functionally complementing
gene (the SGD1 gene) and 0.23 kb from the Ycp50 plasmid, was
further subcloned and partially sequenced directly from the pRS316
vector, using the Sequenase kit, version 2.0 (United States Biochem-
icals, USA), based on the dideoxy chain termination method.
Deletion of the SGD1 gene was performed by subcloning the KpnI^
SalI fragment containing the entire SGD1 gene plus 230 bp of YCp50
into a modi¢ed pBluescript (Stratagene, USA) where the ClaI^XbaI
sites in the polylinker had been removed. A PstI^ClaI fragment from
the promoter-ORF region of the SGD1 gene was removed, the ClaI
end of the remaining insert blunt-ended prior to cutting with PstI.
The released fragment was replaced by the LEU2 gene, cut with PstI
and SmaI in the YDp-L plasmid [24]. The deletion-insertion construct
was cut out with SwaI and HpaI, and transformed into the W303
diploid. The deletion was con¢rmed by Southern blot analysis. Total
DNA was cut with DraI and a 1.68-kb KpnI^HpaI probe of SGD1
gene was used to detect the deletion insertion. Labeling of probe,
hybridization and detection was performed according to the DIG
DNA labeling and detection kits (Roche Molecular Biologicals, Ger-
many). Sporulation of the heterozygous diploids containing the
sgd1v : :LEU2 deletion was performed using standard techniques.
To assess the e¡ect of SGD1 overexpression the 4.8-kb SalI^SalI
fragment was inserted into the 2 W-based YEplac195 vector [25] hav-
ing URA3 as the marker. This plasmid was used to transform the
hog1v : :LEU2 and pbs2v : :LEU2 single or double mutants. To con-
struct a Sgd1p^green £uorescent protein (GFP) fusion, the SGD1 gene
was ampli¢ed with 5P-SpeI and 3P-SalI ends by polymerase chain
reaction (PCR) using the following primers: forward primer with
SpeI-end: 5P-GACTAGTCTCTGCCTTGTCAGCATCATC-3P ; re-
verse primer with SalI-end: 5P-GCGTCGACACGAATCTATATTT-
TCCAG-3P.
The resulting PCR product was cleaved with SpeI and SalI and
cloned in frame at the 5P-SpeI and 3P-XhoI fusion site of the centrom-
er-based vector pAC242 containing the GFP gene sequence [26]. The
SGD1^GFP gene then was tested for suppression of the osg3 mutation
and the SGD1 deletion to demonstrate that the fusion protein was
functional.
2.3. Genetic analysis
To establish whether the DNA fragment complementing the osg3
mutation contained the allelic gene, linkage analysis was performed.
The complementing SalI^SalI fragment was cloned into the integrat-
ing vector pRS406 [23] having URA3 as a marker. The plasmid was
cut open at the NruI site within the putative ORF and transformed
into the osg3 mutant. The resulting transformants were crossed with
strain M2452K and the segregation of the osmosensitive phenotype
was assessed in the tetrads.
2.4. Northern blotting
Total RNA was isolated according to standard procedures [21]
from overnight cultures subjected to osmotic stress (0.7 M NaCl) by
the addition of an equal volume of fresh YNB medium containing 1.4
M NaCl. Gel electrophoresis of RNA, blotting and hybridization
were performed as previously described [11]. The oligonucleotides
used for probing, i.e. 5P-TGTACTATTGGAGCGAAAACTTCT-3P
for GPD1, and 5P-AATCGATTCTCAAAATGGCGTGAGG-3P for
ACT1, were end-labeled with [Q-32P]dATP, using 5 U of polynucleo-
tide kinase (Gibco BRL, Life Technology, USA). To quantify tran-
script levels, the signal intensity was determined with a Molecular
Dynamics (USA) Phosphoimager, each intensity being normalized
to that for ACT1 mRNA.
2.5. Immunoblotting and GFP £uorescence microscopy
To con¢rm expression of Sgd1p^GFP by immunoblot analysis, cells
were grown to mid-logphase in YNB media and collected by centri-
fugation. As control, cells expressing GFP alone from the GAL pro-
moter were precultured in YNB-ra⁄nose (2% w/v) overnight, and
incubated with galactose (2% w/v) for 4 h before collection. After
washing with sterile water the collected cells were resuspended in
PBSMT bu¡er (11.5 g/l Na2HPO4, 80 g/l NaCl, 2 g/l KCl, 0.5 g/l
MgCl2, 0.5% Triton X-100) containing protease inhibitors (0.5 mM
PMSF and 3 Wg/ml each of leupeptin, aprotinin, chymotrypsin and
pepstatin). Glass beads were added and cells were lyzed using a bead
beater at 4‡ with 6-s pulses 6^10 times. A total of 10^20 Wg protein
was resolved by polyacrylamide gel electrophoresis on a 10% gel and
immunoblotted to a nitrocellulose membrane using standard methods
[27]. The membrane was probed with a polyclonal anti-GFP antibody
(gift of J. Kahana and P. Silver, Harvard Medical School, Boston,
MA, USA) and developed using the ECL chemiluminescence kit
(Amersham Pharmacia Biotech AB, Sweden).
For Sgd1p^GFP localization studies, wild-type cells expressing the
Sgd1p^GFP were grown overnight in YNB medium and Sgd1p^GFP
was visualized without ¢xation. Aliquots of 2 Wl were transferred to
microscope slides and covered with coverslips. Cells were viewed
through a GFP optimized ¢lter (Chroma Technology, USA) using a
BX60 epi£uorescence microscope (Olympus) equipped with a Quantix
digital camera (Photometric, USA). The nuclear material stained with
2 Wg/ml of 4P,6-diamidino-2-phenylindole (DAPI) for 10 min, and
visualized under the microscope using a FITC ¢lter.
2.6. Glycerol analysis, preparation of cell-free extracts and enzyme
activity measurements
Cultures for glycerol analysis and enzyme assays were either grown
to an OD610 of approximately 1.0 in YNB medium containing NaCl
as stated in the text, or grown to the same OD610 in YNB medium
lacking salt, followed by a shift to increased salinity by addition of an
equal volume of fresh YNB medium containing an appropriate con-
centration of NaCl. Samples for total glycerol were withdrawn and
determined as previously described [13].
For enzyme activity determination, cells were collected by centrifu-
gation, washed twice in TRED bu¡er (10 mM triethanolamine, 1 mM
EDTA and 1 mM dithiothreitol, pH 7.0), frozen in liquid nitrogen
and stored at 320‡C until used. The preparation of cell-free extracts
and the assay of the speci¢c activity of NAD-dependent GPD were
as described previously [28] except that the bu¡ers contained the fol-
lowing protease inhibitors: 0.5 mM PMSF and 3 Wg/ml each of leu-
peptin, aprotinin, chymotrypsin and pepstatin.
3. Results
3.1. Isolation of the osmosensitive osg3 mutant and cloning of
the SGD1 gene
The osg3 (osmotically sensitive glycerol-defective) mutant
was isolated in S. cerevisiae strain U451 by methods previ-
ously reported [29]. The mutant showed impaired growth on
plates containing more than 0.7 M NaCl (or iso-osmolar con-
centrations of KCl and sorbitol) and displayed a decreased
capacity to increase glycerol production at high external os-
molarities (Fig. 1B). Tetrad analysis of a cross between the
mutant and the wild-type cells exhibited a 2:2 segregation
pattern of the osmosensitive phenotype, indicating the defect
is due to a single mutation. A gene complementing the osg3
osmosensitivity was isolated from a YCp50 DNA library [22].
Plasmid inserts that allowed growth on high osmolarity media
when retransformed into the osg3 mutant were analyzed by
restriction analysis and an overlapping fragment from two
complementing plasmids was chosen for subcloning. A 4.8-
kb SalI^SalI fragment cloned into the centromeric pRS316
vector restored the osmotolerance of the mutant (Fig. 1C).
Similarly, the glycerol production defect exhibited by the mu-
tant at 1.0 M NaCl was restored in transformants containing
the SalI^SalI fragment (data not shown). To conduct linkage
analysis, the SalI^SalI segment was cloned into the integrating
plasmid pRS406, linearized at the NruI site, and transformed
into the osg3 mutant. Diploids were obtained by crossings,
and the segregation of the osmotolerant phenotype was fol-
lowed after sporulation. For 30 complete tetrads, osmosensi-
tive haploid progeny was present in almost all the tetrads
analyzed. From this observation we concluded that we had
cloned a suppressor gene of the osg3 mutation rather than the
wild-type allele of the mutated gene. Partial DNA sequencing
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of subclones of the SalI^SalI fragment and database searches
identi¢ed the gene, termed SGD1, as an open reading frame of
2700 nucleotides on chromosome 12, encoding a hypothetical
protein of 899 amino acids with a calculated molecular weight
of 102.8 kDa (open reading frame YLR336c). The gene was
sequenced by the S. cerevisiae genome project (accession
U19028). The deduced sequence displays 31% identity over
705 amino acids to a hypothetical 87.9-kDa Schizosaccharo-
myces pombe protein of unknown function (accession
Z98601), 27% identical to an ORF in Drosophila melanogaster
(accession AAF47640) and 24% identity over 220 amino acids
to the S. cerevisiae Spt7p, a subunit of the nucleosomal
SAGA complex [30]. Protein motif analysis of Sgd1p showed
overlapping bipartite nuclear localization signals at amino
acid positions 34 to 62 and a leucine zipper region at positions
505 to 536. No region of basic amino acids are found up-
stream of the heptad repeats of leucines, making kinship to
the family of basic leucine zipper transcription factors un-
likely.
3.2. Loss of the SGD1 function is lethal
A deletion of the SGD1 gene was generated by removing
491 codons on the N-terminal side of the SGD1 open reading
frame together with 18 bases upstream of the ATG codon and
replacing this part with the LEU2 gene. A S. cerevisiae W303
diploid homozygous for the leu2 mutation was transformed
with the linearized sgd1v : :LEU2 plasmid and Leu trans-
formants isolated. Deletion of one copy of the SGD1 gene
in the diploids was con¢rmed by Southern blotting. The het-
erozygous SGD1/sgd1v : :LEU diploids were sporulated and
tetrads dissected. From a total of 20 tetrads, 18 contained
only two viable spores, all being Leu3, indicating that
Fig. 1. Glycerol production of wild-type (a) and osg3 mutant (b) after shifting exponentially growing cells cultured in YNB medium to fresh
medium containing (A) 0.7 M NaCl or (B) 1.0 M NaCl. Samples were taken at indicated times after the shift and analyzed for total glycerol
content. Values represent the mean of two independent experiments. C: Suppression of the osg3 mutation by the SalI^SalI clone on high osmo-
larity media. Cells were grown overnight in YNB medium and spotted in 10-fold dilution steps onto YNB plates containing no added NaCl,
1.4 M NaCl or 1.5 M KCl. Growth was assessed after 7 days.
Table 1
Total glycerol production and speci¢c activity of NAD-dependent GPD in wild-type, pbs2v, and hog1v mutant cells carrying the multicopy
YEplac195 vector or the same vector with the SGD1-containing SalI^SalI fragment
Growth
conditions
WT+2 W WT+SGD1-2 W pbs2v+2 W pbs2v+SGD1-2 W hog1v+2 W hog1v+SGD1-2 W
Glycerol
(Wmol/mg dry weight)
0 M NaCl 4.96 6.04 1.96 6.38 4.52 7.02
0.7 M NaCl 13.96 14.24 11.09 26.28 11.08 15.65
GPD activity
(mU/mg protein)
0 M NaCl 40.9 70.8 22.5 35.8 9.3 28.98
0.7 M NaCl 137.2 116 60.6 154.8 59.3 80.3
For glycerol analysis, cells growing exponentially in YNB medium were shifted to fresh medium containing 0 or 0.7 M NaCl followed by fur-
ther incubation for 6 h, whereupon samples were removed. Values are means from two independent experiments. The GPD activities were mea-
sured in desalted crude extracts of cells grown to OD610 = 1.0 in YNB medium containing 0 or 0.7 M NaCl. The enzyme activities represent
means of three independent measurements. Deviation between samples were 6 20%.
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SGD1 encodes an essential gene product. Microscopic analysis
of the non-viable spores showed that some of the spores had
germinated and divided 2^4 times. This indicates that the
SGD1 gene is essential for growth but not for spore germina-
tion.
To further test whether there is an absolute requirement of
SGD1 for cell viability, a heterozygous SGD1/sgd1v diploid
was transformed with the SGD1 gene on pRS316 vector car-
rying the URA3 gene as a marker. The SGD1/sgd1v : :LEU
diploid was sporulated and dissection yielded tetrads with
four viable spores. Viable haploids having Leu Ura pheno-
type were grown in YPD overnight and tested for growth on
YNB plates containing 5-£uoro-orotic acid (5-FOA) and ur-
acil, counter-selecting against the URA3 marker. A wild-type
strain with the SGD1 gene on pRS316 was used as the con-
trol. Loss of the SGD1 gene contained by the URA3 plasmid
resulted in complete loss of viability for the sgd1v : :LEU2
mutant, while a considerable number of the wild-type control
cells survived on the 5-FOA plates (data not shown). An addi-
tional control was performed by plating both strains on YNB
plates lacking 5-FOA on which both formed colonies. From
these experiments, we conclude that loss of the SGD1 gene
product results in cell death, and that SGD1 is required for
mitotic growth and has at least one essential role.
3.3. High dosage of SGD1 rescues HOG pathway mutants on
high osmolarity media
To examine whether SGD1 has a role in the osmoregulatory
response, we transformed hog1v and pbs2v signaling defective
mutants with the SGD1 gene (the SalI^SalI fragment) in the
YEplac195 multicopy plasmid (SGD1-2 W). Increased copies
of the SGD1 gene relieved the sensitivity of pbs2v and hog1v
mutants to 0.7 M NaCl stress (Fig. 2). To assess the basis for
the SGD1-mediated suppression of defects in the HOG path-
Fig. 2. Suppression of the osmosensitive growth phenotype of HOG
pathway mutants by high gene dosage of the SGD1 gene. Growth
of wild-type, pbs2v, hog1v mutants containing the multicopy YE-
plac195 vector or the same vector with the SGD1-containing SalI^
SalI fragment (SGD1). Growth was assessed after 5 days on YNB
medium containing no added NaCl or 0.7 M NaCl.
Fig. 3. Quanti¢ed Northern analysis of GPD1 mRNA in (A) wild-type, (B) pbs2v, (C) hog1v and (D) pbs2vhog1v cells carrying the multicopy
YEplac195 vector (open bars) or the same vector with the SGD1-containing SalI^SalI fragment (shaded bars). Samples were taken at indicated
time points after shifting cells growing exponentially in YNB medium to fresh medium containing 0 or 0.7 M NaCl. Recorded mRNA quanti-
ties were normalized to the control ACT1 mRNA value.
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way, we measured glycerol production and the activity of
GPD (Table 1) for cells exposed to 0 or 0.7 M NaCl, when
carrying an empty vector or SGD1-2 W. The presence of multi-
ple copies of SGD1 did not cause any apparent change in
glycerol production of wild-type cells, while in hog1v and
pbs2v mutants the defective glycerol production was restored
to levels similar to or higher than (pbs2v) for wild-type cells
(Table 1). In a hog1vpbs2v double mutant, the e¡ects of
SGD1-2 W resembled those obtained in the hog1v mutant.
Hence, the introduction of multiple copies of SGD1 enhances
basal as well as the stress-induced levels of glycerol produc-
tion in HOG pathway mutants. Measurements of the activity
of GPD (Table 1), which has a key role in glycerol biosynthe-
sis [13], gave results that paralleled what was observed for
glycerol production. To further analyze the suppression e¡ect
caused by a high copy number of SGD1, we quanti¢ed the
levels of GPD1 transcript in wild-type cells and HOG pathway
mutants, after a shift of cells to increased (0.7 M) NaCl (Fig.
3). The observed e¡ects demonstrated that dosage e¡ects of
SGD1 are exerted at the transcriptional level in the HOG
pathway mutants. While increased dosage has small or insig-
ni¢cant e¡ects on the osmostress-mediated transient induction
of GPD1 in wild-type cells, the decreased and delayed induc-
tion in the pbs2v mutant is restored to not only wild-type
levels but, importantly, also to wild-type kinetics. Hence, in
this mutant the introduction of SGD1-2 W causes restoration
of the HOG pathway defect. In hog1v and hog1vpbs2v mu-
tants there is a similar recovery of the response, but not to the
extent observed for the pbs2v mutant. The SalI^EcoRI region,
containing the portion of the upstream VRP1 gene that is
included in the SalI^SalI fragment, did not cause suppression
when introduced on its own in a multicopy plasmid (pRS424)
into pbs2v or hog1v mutants. Hence, we conclude that it is
the authentic SGD1 gene that is required for the suppression.
3.4. Sgd1p^GFP localizes to the nucleus
Since the assumed function of Sgd1p is likely to be exerted
inside the nucleus, or by control of nuclear entry, a fusion of
the GFP to the C-terminal end of the Sgd1p was constructed,
to allow for in vivo localization of the protein. The SGD1^
GFP gene expressed from its own promoter in a centromeric
plasmid fully suppressed the lethality of the SGD1 deletion as
well as the salt sensitivity of the osg3 mutant (data not
shown), demonstrating that the fusion protein is functional.
Furthermore Western blot analysis demonstrated that the
transformed cells express a GFP-linked protein of the ex-
pected size for Sgd1p^GFP (Fig. 4C). The subcellular distri-
bution, as revealed by Sgd1p^GFP £uorescence, demonstrated
that the protein is concentrated to the cell nucleus and colo-
calizes with DAPI-stained DNA (Fig. 4A). Distribution to the
nucleus was also con¢rmed using indirect immuno£uorescence
with antibodies directed against GFP (data not shown). No
Fig. 4. Subcellular localization of Sgd1p^GFP in living yeast cells and con¢rmation of Sgd1p^GFP expression by Western blot. S. cerevisiae
strain ACY192, expressing Sgd1p^GFP from the centromer-based vector pAC242, was grown in YNB liquid medium to early exponential
phase and cell samples were taken and processed for microscopy as described in Section 2. The same ¢eld of cells was photographed to detect
(A) Sgd1p^GFP-associated £uorescence, (GFP), DNA £uorescence after staining with DAPI or whole cells by Nomarski optics (NM). In living
cells DAPI gives bright staining of mitochondrial DNA, whereas chromosomal DNA gives a di¡use spot. B: Enlarged cells to demonstrate the
distribution of Sgd1p^GFP £uorescence in the nucleus. C: Immunoblot analysis of extracts from overnight cells cultured in selective media and
resolved on a 10% sodium dodecyl sulfate^polyacrylamide gel electrophoresis blotted onto a nitrocellulose membrane. The GFP was detected
by polyclonal anti-GFP antibodies. The left lane shows an extract of cells harboring a control plasmid containing GFP expressed from the
GAL1 promoter, while the right lane shows an extract of cells expressing the Sgd1p^GFP fusion protein from the pAC242 vector. The upper
band has a position corresponding to the expected Sgd1p^GFP size (130 kDa); the lower band probably represents a degradation product.
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obvious in£uence on the nuclear localization of Sgd1p was
observed by the presence of a pbs2v or hog1v mutation or
by exposure of the cells to salt stress (0.7 M NaCl, data not
shown). The distribution of the Sgd1p^GFP £uorescence
within the nuclear region suggests that the protein is enriched
in the nucleolus (Fig. 4B).
4. Discussion
We here report the cloning of SGD1, encoding a nuclear
protein that is essential for cell viability and exhibits a dosage-
dependent suppression of HOG pathway defects. The SGD1
gene was isolated as an extragenic suppressor of the osmosen-
sitive and glycerol-defective phenotype of a S. cerevisiae mu-
tant. This pointed towards a possible function for SGD1 in
the osmoregulatory glycerol response, which involves a con-
trolled induction of GPD1 expression to raise the intracellular
glycerol concentration following exposure to hyperosmotic
stress [29]. This response represents, at least partly, a HOG
pathway-dependent reaction [10], critical for cellular adapta-
tion to high osmolarity conditions. Several observations sug-
gest that an increased copy number of SGD1 suppresses the
osmosensitivity of the HOG pathway mutants by a¡ecting the
expression of the GPD1 gene. High dosage of SGD1 partially
restored the defective transcriptional response of GPD1 in
HOG pathway mutants subjected to osmotic stress (Fig. 2).
In agreement with this ¢nding multicopy expression of SGD1
also promoted increased activity of glycerol-3-phosphate de-
hydrogenase and increased glycerol production (Table 1) in
mutants deleted for PBS2 or HOG1. Somewhat surprizingly,
the restoration of GPD1 expression, GPD activity and glyc-
erol production were stronger in mutants lacking the MAP
kinase activator Pbs2p, than in cells lacking the downstream
MAP kinase, Hog1p. However, the fact that suppression of a
hog1v single mutant was similar to that observed for a
hog1vpbs2v double mutant, suggests that the presence of
Hog1p might be required for an e¡ective suppression of the
osmosensitivity of a signaling defective mutant. These argu-
ments place the function of SGD1 downstream of the HOG
MAPK cascade, consistent with the nuclear residence of the
protein, as demonstrated by the localization pattern of a func-
tional Sgd1p^GFP fusion (Fig. 4). The mechanism whereby
Sgd1p may a¡ect GPD1 transcription is open to speculation.
Since there is no direct experimental evidence that Sgd1p is a
substrate for the HOG pathway we cannot disregard the pos-
sibility that Sgd1p might be operating in a di¡erent regulatory
context. This supposition ¢nds some support in the fact that
Sgd1p exhibits sequence homology in its N-terminal to Spt7p,
a subunit of the nucleosomal SAGA histone acetylation com-
plex [30]. It was recently demonstrated that osmotic induction
of GPD1 requires binding of Rap1p to its promoter and spe-
ci¢c inactivation of all Rap1p binding sites completely abol-
ished the osmotic induction of GPD1 [15]. Rap1p is a DNA
binding repressor activator protein with an array of functions
that all appear to be linked to a chromatin opening property
of the protein [31]. Hence, changes of the chromatin environ-
ment might be a prerequisite for the osmostress-induced acti-
vation of GPD1 expression. Increased dosage of SGD1 might
interfere in this context, mediating activated transcription of
the gene. Participation in such a general function would be in
agreement with the vital role of Sgd1p for yeast growth.
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